Skip to main content
Jason Wang, MD, Other MD/DO, Palo Alto, CA

JasonJianxunWangMD

Other MD/DO Palo Alto, CA

Venture Capital at Frazier Life Sciences

Dr. Wang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Wang's full profile

Already have an account?

  • Office

    1001 Page Mill Rd
    Palo Alto, CA 94304
    Phone+1 989-493-3919

Summary

  • Jason is a Senior Associate on the Frazier Life Sciences team focused on identifying and evaluating new public investment opportunities.

    Prior to joining Frazier Life Sciences, Jason was a Principal at Vivo Capital. At Vivo, Jason evaluated public market biotech companies pursuing transformative treatments. In prior roles, Jason served on the business development team at Fortress Biotech, where he helped create new biotech companies including Hepla Sciences, which focuses on treating metabolic diseases.

    Jason attended medical school at the University of Illinois, where he was awarded an HHMI summer fellowship for basic science research. Jason earned his B.A. in Chemistry and History from the University of Rochester, where he spent two years in Robert Boeckman’s lab studying small molecules as oncology therapeutics.

Education & Training

  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 2016
  • University of Rochester
    University of RochesterBA, Chemistry and History, 2005 - 2009

Awards, Honors, & Recognition

  • USMLE Step 1: 247 NBME, 2014
  • Summer Medical Fellow Howard Hughes Medical Institute, 2012
  • MCAT 38R (99th Percentile) AAMC, 2010

Publications & Presentations

PubMed

Research History

  • Senior Research Fellow• Part of a Multidisciplinary team. Designed and performed experiments for targeted chemotherapy, cardiovascular disease, RSV vaccine for children, and HIV vaccine supervised by our primary investigator. Synthesized nanoparticles, purified and characterized by spectroscopy as quality control. Perfor2010 - 2012

Other Languages

  • Chinese (Mandarin), Spanish

Industry Relationships

  • Senior Associate, Frazier Life SciencesFrazier Life Sciences is a healthcare investment firm focusing on companies developing novel therapeutics. We have two core funds that enable investments across all stages of therapeutics companies2024 - Present
  • Principal, Vivo Capital2021 - 2024